In September 2015, Alkor Bio Group have announced successful transfer of technologies from Europe. 

Alkor Bio Group's Laboratory of Allergology transferred to the production 27 new allergens, including 8 drug allergens at the first half of September.

In mid-July, eight kits for the laboratory diagnosis of the Russian holding GC Alcor Bio received registration of the Ministry of Health of Georgia. Fertility Diagnostics

Surveillance audit for assessment of compliance with the requirement of European Directive 98/79/EC for In Vitro diagnostics medical  devices was conducted on 14^th, April, 2015 in Alkor Bio Company Ltd.

That allows to export this product to the EU market. Today Alkor Bio – developer and manufacturer of the assay kits for immune-enzyme and molecular-genetic analysis – produces more than 60 different kits for in vitro diagnostics and over 400 allergens for in vitro Allergy diagnostic. More than 50 kits are CE-marked. 

At the beginning of 2015 Alkor Bio Group – the Russian developer and manufacturer of the assay kits for laboratory diagnostics - announced the market launch of new service: the Molecular Diagnostics Laboratory has started developing and producing the test systems based on PCR (polymerase chain reaction) for third-party organizations.